Form 4: Avita Medical Director Jeremy Curnock Cook Reports Acquisition of Shares and Stock Options

Director Jeremy Curnock Cook reports acquisition of 9,200 shares of common stock and 3,943 stock options in Avita Medical, Inc.

Summary

• On June 5, 2024, Jeremy Curnock Cook, a director of Avita Medical, Inc., reported acquiring 9,200 shares of common stock.
• These shares were received as an award of Restricted Stock Units (RSUs) that vest 12 months from the grant date.
• Cook also acquired 3,943 stock options with an exercise price of $9.51, exercisable from June 5, 2025, to June 5, 2034.
• Following these transactions, Cook beneficially owns 29,814 shares of common stock, including unvested RSUs, and 3,943 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The acquisition of shares and options by a director could be interpreted slightly positively, suggesting confidence in the company.

Positives

• The acquisition of shares and stock options by a director could be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• Shareholders may view the director's acquisition of shares and options as a positive signal.

Key Dates